ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

Obituary: Ernst Wynder, 77, Linked Smoking, Cancer

July 23, 1999

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

Oblimersen Combination Improves CLL Survival

December 28, 2007